Repligen Corporation reported second-quarter 2026 revenue of US$204.13 million, up from US$182.37 million a year earlier, while net income dropped to US$5.01 million from US$14.87 million and diluted EPS from continuing operations fell to US$0.09 from US$0.26. For the six months ended June 30, 2026, revenue grew to US$398.38 million from US$351.54 million, but net income and EPS declined, highlighting pressure on profitability despite higher sales. The company bought back no additional shares from April 1 to June 30, 2026, having previously repurchased approximately 684,917 shares under long-running programs. The results underscore ongoing margin pressure as a key near-term risk, with the investment narrative focused on whether Repligen can translate revenue growth into durable earnings expansion.
Repligen CorporationNet income and EPS fell despite higher revenue, indicating margin pressure.
